Amundi’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-83
Closed -$1.05K 2172
2025
Q1
$1.05K Buy
83
+5
+6% +$63 ﹤0.01% 2023
2024
Q4
$1.49K Buy
+78
New +$1.49K ﹤0.01% 1998